Preoperative concomitant radiotherapy and chemotherapy in ultrasound-staged T3 and T4 rectal cancer

Tumori

Volumn 89, Issue 2, 2003, Pages 152-156

  Luppi, Gabriele ^a   Santantonio, Mario ^a   Bertolini, Federica ^a   Fiorica, Francesco ^a   Zanelli, Francesca ^a   Gavioli, Margherita ^a   Balli, Mario ^a   Silingardi, Vittorio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chemotherapy; Down staging; Radiotherapy; Rectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CENTRAL VENOUS CATHETER; COMPUTER ASSISTED SCINTIGRAPHY; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LINEAR ACCELERATOR; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PREOPERATIVE CARE; QUALITY OF LIFE; RECTUM CANCER; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOSIS; ULTRASOUND;

EID: 0037869505     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900209     Document Type: Article

References (22)

1. Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT: Local recurrence after surgery without radiotherapy. Dis Colon Rectum, 44: 374-379, 2001.
2. Cohen AM, Minsky BD, Schilsky RL: Cancer of the rectum. In: Cancer, principles & practice of oncology, De Vita VT Jr, Hellman S, Rosemberg SA (Eds), pp 1197-1233, Lippincott-Raven, Philadelphia-New York, 1997.
3. Heald RJ, Moran BJ, Ryall RDH: Rectal cancer. The Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg, 133: 894-899, 1998.
4. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D, Sargenti D: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst, 93: 583-596, 2001.
5. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med, 345: 638-646, 2001.
6. Manenti A, Gavioli M, Santantonio M, Parmiggiani M, Mandolini G, Falchi A, Miselli R, Gabrielli C, Luppi G, Rosi AC, Piccagli I, Romani M: La radioterapia preoperatoria nel cancro del retto. Minerva Chir, 52: 1029-1034, 1997.
7. Minsky BD: Multidisciplinary management of resectable rectal cancer. Oncology, 10: 1701-1704, 1996.
8. Swedish Rectal Cancer Trial: Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 336: 980-987, 1997.
9. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M: Preoperative radiotherapy for resectable rectal cancer: a meta-analyses. JAMA, 284:1008-1015, 2000.
10. Stryker SJ, Kiel KD, Rademaker A, shaw JM, Ujiki GT, Poticha SM: Preoperative "chemoradiation" for stages II and III rectal carcinoma. Arch Surg, 131: 514-518, 1996.
11. Mehta VK, Poen J, Ford J, Eldelstein PS, Vierra M, Bastidas AJ, Young H, Fisher G: Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer. Dis Colon Rectum, 44: 52-58, 2001.
12. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J: Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol, 24: 107-112, 2001.
13. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, MacDonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil and radiation therapy after curative surgery. N Engl J Med, 331: 502-507, 1994.
14. Boulis-Wassif A, Gerard J, Loygue D, Camelot D, Buyse M, Duez N: Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer, 53: 1811-1818, 1984.
15. Akasu T, Sugihara K, Moriya Y, Fujita S: Limitations and pitfalls of transrectal ultrasonography for staging of rectal cancer. Dis Colon Rectum, 40: 10-15, 1997.
16. Wheeler JMD, Warren BF, Mortensen NJ, Ekanyaka N, Kulacoglu H, Jones AC, George BD, Kettlewell MGW: Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum, 45: 1051-1056, 2002.
17. Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH: No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol, 19: 1976-1984, 2001.
18. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Gandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP: Influence of the interval between preoperative radiation therapy and surgery downstaging and on the rate of sphinter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol, 17: 2396-2402, 1999.
19. Bosset JF, Pavj JJ, Bolla M: Four arms phase III clinical trial for T3-T4 resectable rectal cancer comparing preoperative pelvic irradiation to preoperative irradiation combined with fluorouracil and leucovorin with or without postoperative adjuvant chemotherapy. EORTC Radiotherapy Cooperative Group. Protocol n. 22921. EORTC data Center, Brussels, 1992.
20. Frejer J, Bossard N, Romestaing P, Momex F, Chapet O, Trillet-Lenoir V, Gerard JP: Addition of oxaliplatin to protracted fluorouracil, folinic acid and concomitant radiotherapy in rectal cancer: the Lyon R97-03 phase one trial. J Clin Oncol, 9: 2433-2438, 2001.
21. Adell G, Sun XF, Stal O, Klintenberg C, Sjodahl R, Nordenskjold B: P53 status: an indicator for the effect of preoperative radiotherapy of rectal cancer. Radiother Oncol, 51: 169-174, 1999.
22. Edler D, Hallstrom M, Johnston PG, Magnusson I, Ragnhammar P, Blomgren H: Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. Clin Cancer Res, 6: 1378-1384, 2000.